Our purpose was to elucidate how extracellular ATP causes cell death in the retinal microvasculature. Although ATP appears to serve as a vasoactive signal acting via P2X 7 and P2Y 4 purinoceptors, this nucleotide can kill microvascular cells of the retina. Because P2X 7 receptor activation causes transmembrane pores to form and microvascular cells to die, we initially surmised that pore formation accounted for ATP's lethality. To test this hypothesis, we isolated pericyte-containing microvessels from rat retinas and assessed cell viability by trypan blue dye exclusion, detected pores by the uptake of the fluorescent dye YO-PRO-1, measured intracellular calcium with the use of fura-2 and monitored ionic currents via perforated-patch pipettes. As predicted, ATP-induced cell death required P2X 7 receptor activation. However, we found that pore formation was minimal because ATP's activation of P2Y 4 receptors prevents P2X 7 pores from forming. Rather than opening lethal pores, ATP kills by a mechanism involving voltage-dependent calcium channels (VDCC's). Our experiments suggest that when high concentrations of ATP cause nearly all microvascular P2X 7 receptor/channels to open, the resulting profound depolarization opens VDCC's.
Introduction
Evidence is accumulating that ATP serves as a glial-to-vascular signal in the retina.
Consistent with this role, this nucleotide is released by Müller cells, which are the principal glia of the retina and ensheath the vasculature. Furthermore, by activating P2Y 4 and P2X 7 receptors, extracellular ATP causes microvascular pericytes to contract and thereby, lumens to narrow (13) . In this way, ATP is likely to regulate capillary perfusion within the retina.
In addition to a putative physiological role in the regulation of blood flow, P2X 7 receptor activation can cause cell death in retinal microvessels (25). The activation of P2X 7 receptors not only opens the associated ligand-gated channels, but as reported for a number of other types (5, 7, 10, 20, 26) , also results in the formation of large transmembrane pores and apoptotic cell death (13, 25) . Of potential clinical importance, pore formation and cell death during P2X 7 receptor activation are enhanced in diabetic retinal microvessels (13, 25) . Thus, P2X 7 receptors may play a role in the sight-threatening retinopathy caused by diabetes. On the other hand, it seems likely that under physiological conditions, the lethal effects of P2X 7 receptor activation must be blocked because microvascular cell death has dire consequences for visual function. Consistent with purinergic vasotoxicity being prevented, cell death is rare in the microvasculature of the normal adult retina (1, 18) .
To test hypotheses concerning the mechanisms by which the lethality of P2X 7 receptor activation is held in abeyance, we performed experiments on pericyte-containing microvessels freshly isolated from the adult rat retina. We now report that there are potent mechanisms to minimize the vasotoxicity of extracellular ATP, which is an endogenous agonist for P2X 7 receptors. One protective mechanism involves P2Y 4 purinoceptors whose activation triggers events that inhibit P2X 7 pore formation. Since ATP is a ligand for both P2Y 4 receptors and P2X 7 receptors, cell death due to the opening of pores is minimized during exposure of retinal microvessels to this endogenous nucleotide.
However even though P2X 7 pore formation is prevented during ATP exposure, we found that this nucelotide can kill microvascular cells. Our experiments indicate that ATP's lethality is dependent upon the activation of voltage-dependent calcium channels (VDCC's).
Of potential importance, the VDCC-mediated vasotoxicity of ATP can be prevented by nitric oxide (NO), which is known to inhibit these calcium channels in retinal microvessels (22) . 
Materials and Methods

Microvessel isolation. Animal use conformed to the guidelines of the Association for
Research in Vision and Ophthalmology and the University of Michigan Committee on the Use and Care of Animals. As detailed previously (13), 6-to 8-week Long-Evans rats (Harlan Sprague-Dawley, Inc., Indianapolis, IN and Charles Rivers, Cambridge, MA) were killed with a rising concentration of carbon dioxide, and their retinas were rapidly removed and incubated in 2.5 ml Earle's balanced salt solution, which was supplemented with 0.5 mM EDTA, 20 mM glucose, 15 U papain (Worthington Biochemicals, Freehold, NJ), and 2 mM cysteine for 30 min at 30°C and bubbled with 95% oxygen-5% carbon dioxide in order to maintain pH and oxygenation. After transfer to solution A (140 mM NaCl, 3 mM KCl, 1.8 mM CaCl 2 , 0.8 mM MgCl 2 , 10 mM Na-Hepes, 15 mM mannitol, and 5mM glucose at pH 7.4 with osmolarity adjusted to 310 mosmol 1 -1 ), each retina was gently sandwiched between two glass coverslips (15 mm diameter, Warner Instrument Corp., Hamden, CT). Vessels adhered to the coverslip that contacted the vitreal side of the retina. By repeating this tissue print step, several coverslips containing microvessels could be obtained from a retina.
YO-PRO-1 uptake.
A coverslip with freshly isolated pericyte-containing microvessels was positioned in a chamber located on the stage of a Nikon Eclipse TE300 or E800 microscope (Nikon, Toyko) equipped for fluorescence using X20 objectives. Microvessels were exposed for a total of 90 min to solution A supplemented with 5 µM YO-PRO-1 (Molecular Probes, Eugene, OR), which is a 629 Da propidium di-iodide dye that results in a detectable fluorescence when it binds to nucleic acids after its entry into a cell. In experimental groups with ATP or BzATP, these agonists were present in the YO-PRO-containing solution for the final 60 min of incubation. When UTP was used, it was present for the entire 90 min of exposure to the YO-PRO-containing solution. In experiments using BAPTA-AM or bromoenol lactone, these chemicals were present for the entire 90 min of YO-PRO-exposure plus an additional 30 min pre-incubation period in solution A. For each group, the percentage of YO-PRO-positive cells was determined after 30 min and again after a total of 90 min of exposure to a solution containing YO-PRO-1. Differential interference contrast optics facilitated detection of cells lacking fluorescence; more than 70 microvascular cells per coverslip were examined. In control experiments in which microvessels were exposed the solution A with YO-PRO-1 and no other additives, the percentage of cells positive for this C-00380-2004.R1 6 dye increased from 7.3% (SD 0.6, n = 10) at 30 min to 11.2% (SD 0.6) at 90 min. In the experimental groups, the induced YO-PRO uptake was calculated by subtracting 3.9%, i.e., the increase in controls, from the difference between the 30 and 90 min values.
Electrophysiology. The perforated-patch configuration of the patch-clamp technique was used to monitor ionic currents from pericytes located on microvessels that had been isolated from a retina within 3 h. A coverslip with microvessels was placed in a recording chamber (volume = 1 ml), which was perfused at ~1.5 ml min -1 . Initially the perfusate was solution A.
Vessels were examined at X300 magnification with an inverted microscope equipped with phase-contrast optics. Pericytes were identified by their characteristic "bump on a log" location on the abluminal wall of microvessels (16, 24) . Pipettes were filled with50 mM KCl, 64 mM K 2 SO 4 , 6 mM MgCl 2 , 10 mM K-Hepes, 240 µg ml . When measured in solution A, the pipette resistances were typically 5 M . After a pipette was mounted in the holder of a patch-clamp amplifier (Dagan Corp., Minneapolis, MN), its tip was sealed onto the cell body of phase-bright pericyte. As amphotericin/nystatin perforated the patch, the access resistance to the pericytes studied decreased to less than 25 M within 5 min. Pericytes were voltageclamped and currents were filtered at 1 kHz with a four-pole Bessel filter, digitally sampled every 250 µs using a DigiData 1200B acquisition system (Axon Instruments, Union City, CA) and stored by a computer equipped with pCLAMP 8 (Axon Instruments) and Origin (Version 7, OriginLab, Northampton, MA) software for data analysis and graphics display. As detailed previously (13), the peak amplitude of the inward current induced during 3 min of exposure to a perfusate containing ATP or BzATP (benzoylbenzoyl-ATP) was quantified from continuous recordings of pericytes that were voltage-clamped at -103 mV, the equilibrium potential for potassium. The zero-current potential was defined as the membrane potential.
Adjustment for the calculated liquid junction potential (2) was made after data collection. Freshly isolated microvessels were exposed to purinergic agonists for 24 h and then cell viability was quantified. UTP, nifedipine, sodium nitroprusside or brilliant blue were present starting approximately 30 min prior to the addition of ATP or BzATP. In experiments using oxidized-ATP, freshly isolated microvessels were incubated for 2 h at 37 o C with this antagonist prior to the addition of ATP. In protocols using bromoenol lactone, this chemical was present for 60 min prior to the addition of BzATP. In protocols using 1,2-bis(2-aminophenoxy)ethane-N,N,N'N'-tetraacetic acid-AM (BAPTA-AM), microvessels were exposed to this calcium chelator for 60 min prior to switching to a BzATP-containing, BAPTA-free solution. In control experiments in which microvessels were maintained in solution A for one day, cell death was 12% (SD 4, n = 18). In experimental groups, the induced cell death was calculated by subtracting this value, i.e., 12%, from the percentage of microvascular cells that were trypan blue positive after a 24 h exposure to experimental conditions. Calcium imaging. Freshly isolated microvessels were loaded with 1µM fura-2AM (Molecular Probes, Eugene, OR) at 37ºC for 30 minutes. Subsequently, the extracellular fura-2AM was washed out with solution A for approximately 30 minutes to provide time for the AM ester to be cleaved. A coverslip containing fura-loaded microvessels was positioned in a perfusion chamber (volume = 1 ml), which was perfused at ~1.5 ml min -1 . Digital imaging of fluorescence was performed at room temperature using an intensified CCD camera with a 12-bit dynamic range (Sensicam, Cooke Corp., Auburn Hills, MI); the light source was a high intensity mercury lamp coupled to a monochromator (Cairn Research Ltd., Faverhsam, UK).
Imaging Workbench 5 (Indec BioSystems, Mountain View, CA) was used to control the imaging equipment and collect data. Using a Nikon Eclipse TE300 microscope at X400 using a X40 oil objective, we measured fluorescent intensities at 340 nm and 380 nm from pericyte somas, which were defined as regions of interest (ROI's) using the imaging software.
Subsequently, the 340:380 fluorescence ratio was calculated. Conversion to intracellular calcium concentration was achieved by using the equation of Grynkiewicz et al. (9) in which R min and R max were determined by measuring the fluorescence ratio in fura-loaded pericytes located on freshly isolated microvessels exposed to calcium calibration buffer solutions (C- 
Results
Inhibition of P2X 7 pore formation
In earlier studies (13, 25), we found that exposure of isolated retinal microvessels to the P2X 7 agonist BzATP (benzoylbenzoyl-ATP) results in the opening of P2X 7 receptor/channels and also the opening of transmembrane pores, which are permeable to the 629 Da fluorescent molecule YO-PRO-1. Associated with P2X 7 pore formation, apoptosis is triggered in the retinal microvasculature (25).
Based on the idea that the microvascular lethality of ATP (25), which is an endogenous P2X 7 ligand, is caused by the formation of lethal P2X 7 pores, we began the present study by assessing the effect of this nucleotide on the uptake of YO-PRO-1 into cells of the pericyte-containing retinal microvasculature. Unexpectedly, we found that less than 4% of the microvascular cells became positive for YO-PRO-1 during exposure to 3 mM ATP, which is the maximally effective concentration of this nucleotide for inducing P2X 7 currents in retinal pericytes ( Figure 2 ). In contrast, markedly (P < 0.001) more microvascular cells, i.e., 36%, became YO-PRO positive during exposure to 100 µM BzATP, even though this is a submaximally effective dose for inducing P2X 7 currents ( Figure 2 ). The relative paucity of pores opened during exposure to ATP suggested that although this nucleotide activates P2X 7 receptor/channels, the subsequent formation of pores is prevented.
Because ATP is a ligand for numerous types of purinoceptors, we considered the possibility that ATP's activatation of non-P2X 7 receptors triggers events that inhibit the formation of P2X 7 pores. A candidate for playing this inhibitory role is the P2Y 4 receptor, which is activated in rat retinal microvessels by ATP (13) . Because extracellular UTP activates microvascular P2Y 4 receptors, but not the P2X 7 receptors (13), we used UTP to test the effect of P2Y 4 receptor receptor activation on the ability of the P2X 7 agonist BzATP to induce pore formation. In a series of experiments, we observed that UTP (30 µM) markedly (P = 0.001) diminished the BzATP-induced uptake of YO-PRO-1 ( Figure 1 ). These findings are consistent with the UTP-sensitive P2Y 4 receptors triggering events that inhibit the formation of P2X 7 pores.
To further support our conclusion the exposure to UTP inhibits the opening of P2X 7 pores, we performed electrophysiological assays in which extracellular sodium was replaced by N-methyl-D-glucosamine (NMDG + ), which is a 195 Da cation that passes through P2X 7 C-00380-2004.R1 10 pores, but not through P2X 7 receptor/channels (27) . Thus, under these conditions, an inward current generated by the influx NMDG + indicates that pores are opened. As illustrated in Figure 3A , the amplitude of the NMDG + current induced in pericytes by 100 µM BzATP was markedly smaller when the perfusate contained UTP. This inhibitory effect of UTP was reversible, although a washout for >20 min was required. We obtained four recordings similar to the one illustrated in Figure 3A ; in this series of recordings, the NMDG + current induced by 100 µM BzATP was inhibited by inhibited by 88% (SD 8, P = 0.038) when 30 µM UTP was in the perfusate. The number of pericytes that we successfully monitored during exposure to BzATP in the absence and also the presence of UTP was limited because prolonged recordings were required due to the >20 min needed to reverse BzATP's effects on microvascular currents (13) . Thus, in another series of experiments, we used an experimental protocol that allowed us to confirm in a larger number of sampled pericytes that UTP inhibits P2X 7 pore formation. Specifically, we measured the peak amplitude of the BzATP-induced current in pericytes exposed to an NMDG + -containing perfusate that either lacked (n = 18) or contained 30 µM UTP (n = 10). As shown in Figure 3B , the amplitude of the NMDG + current induced by 100 µM BzATP was 83% smaller (SD 6, P = 0.002) if the pericyte-containing microvessels were exposed to UTP.
In other electrophysiological experiments, we compared the amplitude distribution of BzATP-induced inward current in pericytes exposed to a sodium-containing perfusate (solution A) without or with 30 µM UTP (Figure 4 ). In the absence of UTP, induced inward currents of >150 pA were detected in 38% of the sampled pericytes (n = 32). However, when UTP was in the perfusate, BzATP-induced currents of >150 pA were not detected in any of 28 sampled pericytes; this was a significant difference (P < 0.001, Fisher exact test). The absence of relatively large sodium currents induced by BzATP in the presence of UTP is consistent with the opening of fewer high conductance pores in the UTP-treated microvascular cells, although the inability to selectively quantify the current passing through In other experiments, we considered the possibility that the activation of phospholipase A 2 is a step in the sequence of events linking UTP-sensitive receptor activation with the inhibition to pore formation. This putative mechanism was of interest because this enzyme appears to regulate the formation of P2X 7 pores in submandibular acinar cells (4) . As shown in Figure 1 , the inhibitory effect of UTP on the BzATP-induced uptake of YO-PRO-1 was reduced by 85% (SD 20, P = 0.009) when microvascular cells were exposed to the phospholipase A 2 inhibitor, bromoenol lactone (BEL). Our experiments using BAPTA and BEL suggest that the activation of UTP-sensitive receptors inhibits the formation of P2X 7 pores by a mechanism involving calcium and PLA 2 .
Inhibition of P2X 7 -induced cell death
We asked whether the UTP-induced inhibition of pore formation affected the lethality of 100 µM BzATP. As shown in Figure 4 , exposure to UTP markedly diminished the microvascular cell death induced by this concentration of BzATP. Conversely, substantial BzATP-induced death occurred when BAPTA or BEL blocked the UTP-mediated inhibition of pore formation ( Figure 5) . Thus, the formation of pores correlated with the induction of cell death in retinal microvessels exposed to 100 µM BzATP.
We also considered the possibility that UTP prevents BzATP-induced microvascular cell death by inhibiting the L-type voltage-dependent calcium channels (VDCC's) expressed in the pericyte-containing microvasculature (22, 24) and that may be activated by the depolarization caused by the opening of P2X 7 receptor/channels. These VDCC's were of C-00380-2004.R1 12 interest because previously we found that their opening can cause cytotoxicity in retinal microvessels (14) . To assess the role of VDCC's in mediating the lethality of 100 µM BzATP, we exposed microvessels to nifedipine, which is known to inhibit the VDCC's of retinal microvessels (22, 24) . As shown in Figure 5 , 10 µM nifedipine did not significantly (P = 0.48) affect the lethality of 100 µM BzATP. This failure of nifedipine indicates that the mechanism of action for UTP's protective effect is not due to an inhibition of VDCC's; otherwise nifedipine should have also been effective. A parsimonious explanation is that UTP initiates events that prevent lethal pores from opening during P2X 7 receptor activation.
High dose BzATP-induced death: role of pores and VDCC's
In another series of experiments, we assessed mechanisms by which 500 µM, rather than 100 µM, BzATP cause microvascular cell death. The higher concentration was of interest because it is the maximally effective BzATP dose for killing cells in retinal microvessels (25) and for activating an inward current in pericytes (Figure 2) . We found that similar to the situation with 100 µM BzATP, the uptake of YO-PRO-1 during exposure to 500 µM BzATP was significantly (P = 0.016) diminished in the presence of 30 µM UTP ( Figure   6A ). However, unlike our findings with 100 µM BzATP, UTP did not significantly (P = 0.36) inhibit the cell death induced by 500 µM BzATP ( Figure 6B ) even though the P2Y 4 agonist inhibited pore formation. This finding suggested that 500 µM BzATP, unlike 100 µM BzATP, can trigger microvascular cell death by multiple mechanisms; one of which does not require opening of P2X 7 pores.
We hypothesized that a pore-independent mechanism by which 500 µM BzATP causes cell death may involve microvascular VDCC's. Although VDCC activity does not appear to be essential for cell death to be induce by 100 µM BzATP (Figure 5 ), we reconsidered the role of these calcium channels in the vasotoxicity caused by 500 µM BzATP.
VDCC's were of interest because 500 µM BzATP induced a significantly (P= 0.001) greater depolarization of sampled pericytes than a 100 µM concentration of this P2X 7 agonist.
Specifically, 500 µM BzATP decreased from the resting membrane potential from -43 mV (SD 6) to -18 mV (SD 6, n = 4); in contrast, as we reported previously (13), 100 µM BzATP induced a depolarization to only -27 mV (SD 4). The greater depolarizing effect of 500 µM BzATP, as compared with 100 µM BzATP, correlates with a calculated P2X 7 receptor C-00380-2004.R1 13 occupancy of 92% at the higher BzATP concentration and 71% at the lower dose (assuming a Hill coefficient of 1 and, as derived from Figure 2 , an EC 50 of 40 µM for the BzATP-induced current; a similar BzATP EC 50 value is reported for cloned rat P2X 7 receptors assayed in a bathing solution similar to the one used in this study). Based on previous studies (22, 24) , we surmised that the greater voltage shift induced by 500 µM BzATP, as compared with 100 µM BzATP, would result in more calcium influxing through the microvascular VDCC's.
Consistent with this, we detected a nifedipine-sensitive rise in pericyte calcium during exposure of microvessels to 500 µM BzATP, but not to 100 µM BzATP ( Figure 6C ). Our inability to detect a nifedipine-sensitive increase in pericyte calcium during exposure of microvessels to 100 µM BzATP not only supports the idea that this concentration of the P2X 7 agonist does not activate a significant number of VDCC's, but also indicates that this dihydropyridine does not have a detectable effect on the flux of calcium through P2X 7 receptor/channels.
In agreement with the hypothesis that VDCC's play a role in the cell death induced by 500 µM BzATP, nifedipine (10 µM) in the presence of 30 µM UTP significantly (P = 0.022) diminished the lethality of this relative high BzATP concentration ( Figure 6B ). Consistent with 500 µM BzATP activating multiple lethal pathways, we found that nifedipine in the absence of UTP did not significantly (P = 0.48) affect cell death induced by this concentration of BzATP ( Figure 6B ). Because inhibition of VDCC's alone is insufficient to block cell death induced by 500 µM BzATP, we not unexpectedly found that exposure of microvessels to a donor of nitric oxide, which inhibits the microvascular VDCC's (22), failed to affect BzATP's lethality ( Figure 6B ). Based on these experiments, we concluded that two lethal mechanisms are triggered by 500 µM BzATP. One mechanism is dependent upon the formation of P2X 7 pores, and the other is a VDCC-dependent process. Both mechanisms must be blocked in order to prevent cell 500 µM BzATP from causing microvascular cells to die.
ATP-induced microvascular cell death
In another series of experiments, we assessed the role of the pore-dependent and the VDCC-dependent pathways in mediating the cell death induced by the endogenous purinergic agonist, ATP. As shown in Figure 7A , this nucleotide casued microvascular cell death in a dose-dependent manner. Consistent with the importance of P2X 7 receptors, ATP's lethality was significantly (P 0.008) decreased by the P2X 7 receptor blockers, 2'3'-dialdehyde-ATP C-00380-2004.R1 14 (oxidized-ATP) and brilliant blue ( Figure 7B ). However, even though P2X 7 receptors play an important role, YO-PRO uptake was detected in relatively few microvascular cells exposed to a high concentration of extracellular ATP (Figure 1) . Thus, we suspected that the activation of VDCC's, rather than the opening of P2X 7 pores, was the critical event leading to ATPinduced cell death. This seemed to be a reasonable possibility because our electrophysiological recordings demonstrated that 3 mM ATP caused the membrane potential of pericytes to decrease to from -42 mV (SD 6) to -19 mV (SD 2, n = 4), which is similar (P = 0.77) to the effect on pericyte voltage of 500 µM BzATP. Consistent with VDCC's being activated during exposure to ATP, the intracellular calcium concentration during the plateau phase of pericytes' response to 3 mM ATP was decreased significantly (P < 0.001, n = 18) by 10 µM nifedipine ( Figure 6C & 8A) . Supporting a role for VDCC's in the microvascular cell death caused by 3 mM ATP, we observed that nifedipine (10 µM) decreased ATP-induced cell death by 96% (SD 21, P < 0.00, Figure 8B ). Taken together, our experiments indicate that the ATP's cytotoxicity in retinal microvessels is not due to the formation of P2X 7 pores, but rather is due to VDCC's that open when a near-maximal activation of microvascular P2X 7 receptor/channels causes a profound depolarization.
Nitric oxide inhibits ATP-induced cell death.
Because microvascular cell death would have an adverse effect on retinal function, we postulated that there are protective mechanisms to control the lethality of ATP. As detailed in this study, one protective mechanism involves the activation of a P2Y 4 receptor/calcium/PLA 2 pathway that inhibits the formation of potentially lethal pores. However, based on the experiments described above, the prevention of ATP-induced microvascular cell death would also require that VDCC activation be limited. Because we previously reported that nitric oxide (NO) inhibits microvascular VDCC's (22), we hypothesized that this gas could limit cell death in microvessels exposed to ATP. In agreement with this idea, we found that the nitric oxide donor, sodium nitroprusside (100 µM), significantly (P < 0.001) decreased cell death during exposure of retinal microvessels to 3 mM ATP ( Figure 8B 
Discussion
This study shows that extracellular ATP induces cell death in retinal microvessels by a mechanism involving the activation of P2X 7 receptors. Previously, we demonstrated that the selective activation of these ligand-gated channels results in the formation of large transmembrane pores and the triggering of apoptosis in the retinal microvasculature (13, 25) .
Hence, our initial hypothesis was that P2X 7 pore formation accounts for the microvascular death induced by ATP, which is an endogenous P2X 7 agonist. However, inconsistent with this hypothesis, we found that pore formation in microvascular cells was minimal despite the exposure of microvessels to lethal concentrations of ATP. Our experiments revealed that ATP's activation of P2Y 4 receptors triggers a series of events that prevent pores from forming during the activation of microvascular P2X 7 receptors.
Rather than killing microvascular cells by causing P2X 7 pores to form, the vasotoxicity of ATP is mediated by the activation of voltage-dependent calcium channels (VDCC's). These calcium channels open when a near-maximal activation of a microvessel's P2X 7 receptor/channels causes a profound depolarization that shifts the membrane potential into the so-called "window of current" (12) where VDCC's are activated, but not completely inactivated (24) . As a result, a pathway for a sustained influx of calcium is opened. Based on other studies of retinal microvessels (14, 23) , it is known that an influx of calcium via VDCC's can result in cytotoxicity within the retinal microvasculature, although future studies are needed to determine the minimal duration of ATP-induced VDCC activation required for microvascular cells to become mortally damaged. Consistent with the scenario in which VDCC's mediate the lethal effect of ATP, the vasotoxicity of this endogenous nucleotide was prevented by exposure of retinal microvessels to the VDCC blocker nifedipine or to a nitric oxide (NO) donor known to inhibit these microvascular channels (22) . Although it remains uncertain whether the inhibition of VDCC's is the only mechanism by which nifedipine and NO protect against the vasotoxicity of ATP, it seems likely that these calcium channels are key players. A parsimonious explanation of our experimental observations is that the NO-mediated inhibition of VDCC's and the P2Y 4 -mediated inhibition of P2X 7 pore formation prevent extracellular ATP from killing microvascular cells ( Figure 9A ) and thereby, allow this nucleotide to serve as a nonlethal vasoactive signal in the retina ( Figure 9B This study provides the first demonstration that extracellular signaling molecules regulate the effectiveness by which the activation of P2X 7 receptors results in the formation of transmembrane pores. Although much remains to be learned, the mechanism by which P2Y 4 receptors inhibit pore formation in microvascular cells appears to involve calcium, which is released from intracellular stores when these purinoceptors are activated (13) . Consistent with the importance of calcium in blocking P2X 7 pore formation, chelation of this divalent cation prevented the P2Y 4 receptor ligand, UTP, from inhibiting the formation of pores during the selective activation of P2X 7 receptors by BzATP.
Even though the release of stored calcium during P2Y 4 receptor activation is associated with a profound inhibition of P2X 7 pore formation, it is uncertain why a seemingly similar rise in cytosolic calcium caused by influx of this cation through P2X 7 receptor/channels (13) is less effective in blocking the formation of pores (Figure 1) . One likely explanation for this apparent discrepancy is that by measuring the average concentration of free calcium throughout pericyte somas, we did not detect localized subcellular calcium increases that may be of functional significance. Perhaps, calcium released from intracellular stores, as compared with calcium entering via P2X 7 receptor/channels, more effectively increases calcium levels adjacent to sites where pore formation is regulated. Alternatively, the emptying of calcium stored in the endoplasmic reticulum may be a signal to inhibit the formation of P2X 7 pores within the plasma membrane. Our experiments also do not exclude a P2Y 4 -triggered signal, in addition to the release of calcium, that is necessary for the inhibition of P2X 7 pore formation.
Suggestive that an isoform of phospholipase A 2 links P2Y 4 receptor activation with P2X 7 pore formation, we found that the opening of pores was markedly inhibited by bromoenol lactone (BEL), which is an inhibitor of calcium-insensitive phospholipase A 2 (iPLA) (11) . At present, it is uncertain whether there is a causal relationship between the P2Y 4 -mediated release of calcium and the activation of this PLA 2 isoform. A link is possible because although cell-free assays suggest that iPLA 2 activation is independent of calcium, experimental evidence suggests that this isoform may be regulated within cells by calcium (15) . However, although our experiments with BEL point to a role for iPLA 2 in regulating pore formation, a caution is that BEL also can inhibit other enzymes (15) . If iPLA 2 is important, then a goal for the future is to elucidate the mechanism by which its activation blocks the opening of P2X 7 pores. One possibility is that iPLA 2 -induced changes in the lipid composition of the cell membrane interfere with the formation of pores. However, until the sequence of events linking the activation of P2X 7 receptor/channels with the opening of transmembrane pores is more completely elucidated, it will not be feasible to fully characterize the mechanism by which the activation of P2Y 4 receptors inhibits the formation of P2X 7 pores.
We postulate that in order to warrant the potential risk of triggering apoptosis, the capability of microvascular cells to form P2X 7 pores must provide a considerable adaptive advantage for the retina. However, the physiological role of P2X 7 pores in the normal functioning of microvessels is unclear. We speculate that although the concomitant activation of P2Y 4 A goal for the future is to elucidate the role of P2X 7 pores in retinal microvascular physiology. We propose that one of the roles for the pores that do open, despite P2Y 4 activation, is to provide calcium influx pathways that functionally complement the other ATPactivated calcium permeable pathways, i.e., P2X 7 receptor/channels (13) and the VDCC's ( Figure 9A ). In addition, pore formation is likely to allow molecules of up to 900 Da to enter and leave microvascular cells; however, at present, the functional implications of this exchange are unknown. Based on our studies, it appears that the number of pores formed and VDCC's opened is tightly regulated in the normal retinal microvasculature by mechanisms such as the P2Y 4 -mediated suppression of P2X 7 pore formation and the NO-induced inhibition of VDCC's. As a result, pores and VDCC's can play a role in mediating the purinergic regulation of capillary function without triggering the apoptosis of microvascular cells.
There are a number of potential sources of extracellular ATP that could activate the purinoceptors in retinal microvessels. It seems likely that only locally released ATP activates this microvasculature's purinergic receptors because blood vessels in the retina lack extrinsic autonomic input (28) , which in other vascular beds is a source of ATP (21) . One local source of ATP is the glia whose processes ensheath retinal vessels and release this nucleotide (19) , which may reach high concentrations in the limited space between the glial processes and the abluminal vascular wall. Other potential sources of extracellular ATP include the vascular endothelium, activated platelets and hypoxic red blood cells (3, 8) . In addition, relatively high concentrations of ATP can leak from damaged cells (17) . Thus, under both physiological and pathophysiological conditions, it seems likely that microvascular cells of the retina can be exposed to ATP.
Our conclusions concerning the mechanism by which ATP induces microvascular cell death are based on experiments using freshly isolated retinal microvessels. One benefit of studying microvessels in isolation is that confounding effects mediated by non-vascular retinal cells are eliminated. Also, it is possible to precisely control the concentrations of agonists and inhibitors, as well as the duration of exposure to these chemicals. On the other hand, it remains to be demonstrated that potentially vasotoxic concentrations of this nucleotide can occur adjacent to retinal microvascular cells in vivo. Also, the roles of P2Y 4 receptors and nitric oxide in minimizing the vasotoxicity of ATP await confirmation in vivo.
Clearly, an in vivo application of the viability, imaging and electrophysiological techniques used in this study would be ideal. However, this does not appear to be feasible at present.
Hence, despite some caveats, microvessels freshly isolated from the retina provide a useful experimental preparation in which to make new observations that can lead to new hypotheses concerning the physiology and pathobiology of the pericyte-containing microvasculature.
In summary, experiments using isolated microvessels indicate that extracellular ATP serves not only as a vasoactive signal, but can kill cells in the pericyte-containing microvasculature of the retina. Our recent demonstration that early in the course of experimental diabetes the formation P2X 7 pores is enhanced in retinal microvessels (25) suggests that purinergic vasotoxicity may play a role in the microvascular cell death that is a hallmark of diabetic retinopathy (6, 18) . However, because microvascular cell death would be detrimental for visual function, it seems essential that the lethal effects of extracellular ATP must be prevented in the normal adult retina. Our findings that the activation of P2Y 4 receptors inhibits P2X 7 
